prof. dr. H.J. Haisma
Hidde Haisma was awarded an MSc in medical biology at the University of Utrecht, The Netherlands in 1983; he then worked as a scientist at Centocor Inc. Malvern, PA, USA (1985–1986), Dana Farber Cancer Institute, Brigham and Women’s Hospital Boston MA, USA (1986–1987), and as an instructor at Harvard Medical School, Boston MA, USA (1986–1987). In 1987, he was awarded his PhD by the University of Utrecht, The Netherlands for his thesis entitled ‘Monoclonal antibodies and cancer’. From 1987 to 1997, he worked as a scientist in the Section for Experimental Therapy of the Department of Medical Oncology, University Hospital of Amsterdam, The Netherlands, where, in 1997, he was appointed assistant professor/section leader of the Division of Gene Therapy. In 2000, he became a full professor at the University of Groningen, The Netherlands. Haisma’s research is devoted to the development of genetic medicines for therapeutic intervention of gene expression in patients. He is member of the editorial board of several journals, has co-authored over 150 publications, and holds several patents. Haisma is the former president and member of the board of The Dutch Society of Gene and Cell Therapy. In addition, he is member of the Gene and Cell Doping Expert Group of the World Anti-Doping Agency (WADA).
|Last modified:||15 September 2021 4.27 p.m.|